Key Market Indicators
Hungarian insulin exports are projected to reach approximately $88 million by 2028, up from around $79 million in 2023. This marks an average annual growth rate of 1.5%. Since 2001, Hungary's insulin supply has increased by 1.6% annually. In the global rankings for 2023, Hungary secured the 7th position, with India slightly ahead at $79 million. France, Italy, and China occupied the 2nd, 3rd, and 4th spots, respectively. On the import front, Hungary's insulin imports are expected to grow to nearly $279 million by 2028, up from about $240 million in 2023. This represents a compound annual growth rate (CAGR) of 2.3%. Since 1997, Hungarian demand for insulin has risen by 3% annually.
